Article Citation
Li HT, Du YY, Huang Z, Li JJ, Zhang J. Significance of monitoring imatinib plasma concentration in second-line treatment decisions for c-kit 11 gene-mutated gastrointestinal stromal tumors. World J Gastrointest Oncol 2025; 17(3): 98746 [PMID: 40092944 DOI: 10.4251/wjgo.v17.i3.98746]
Please LOGIN to submit a new comment.